In a groundbreaking retrospective cohort study published in the highly respected journal JAMA Oncology, researchers have unveiled compelling evidence that…
CDMO Andelyn Biosciences partnered with Amplo Biotechnology, which focuses on adeno-associated virus (AAV) regenerative medicines for neuromuscular junction-(NMJ) affecting conditions,…